We are live on ! Find out more
Citigroup

Citigroup Portfolio holdings

AUM $235B
1-Year Est. Return 32.99%
 

Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.

This Fund
S&P 500
This Quarter Est. Return
+8.35%
1 Year Est. Return
+32.99%
3 Year Est. Return
+97.19%
5 Year Est. Return
+117.91%
10 Year Est. Return
+456.21%
AUM
$166B
AUM Growth
+$11.6B
Cap. Flow
-$367M
Cap. Flow %
-0.22%
Top 10 Hldgs %
20.23%
Holding
6,654
New
397
Increased
2,681
Reduced
2,205
Closed
444

Sector Composition

Rank Sector Weight
1 Technology 12.22%
2 Financials 7.52%
3 Healthcare 6.46%
4 Consumer Discretionary 6.41%
5 Communication Services 4.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BYU
5551
DELISTED
BAIYU Holdings, Inc. Common Stock
BYU
$9K ﹤0.01%
37
-8
-18% -$2.41K
JOAN
5552
DELISTED
JOANN, Inc. Common Stock
JOAN
$9K ﹤0.01%
552
-61,982
-99% -$849K
EBET
5553
DELISTED
EBET, INC. Common Stock
EBET
$9K ﹤0.01%
+15
New +$9.91K
OYST
5554
DELISTED
Oyster Point Pharma, Inc. Common Stock
OYST
$9K ﹤0.01%
530
+128
+32% +$2.43K
PZN
5555
DELISTED
Pzena Investment Management, Inc. Class A
PZN
$9K ﹤0.01%
837
-320
-28% -$3.53K
MBII
5556
DELISTED
Marrone Bio Innovations, Inc.
MBII
$9K ﹤0.01%
5,335
+745
+16% +$1.25K
SRGA
5557
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
$9K ﹤0.01%
220
-219
-50% -$11.2K
JHB
5558
DELISTED
Nuveen Corporate Income November 2021 Target Term Fund
JHB
$9K ﹤0.01%
1,000
GPX
5559
DELISTED
GP Strategies Corp.
GPX
$9K ﹤0.01%
599
-266
-31% -$4.31K
ADN
5560
DELISTED
Advent Technologies
ADN
$8K ﹤0.01%
+27
New +$8.98K
AVTX icon
5561
Avalo Therapeutics
AVTX
$1.02B
$8K ﹤0.01%
1
BDSX icon
5562
Biodesix
BDSX
$220M
$8K ﹤0.01%
29
+19
+190% +$5.97K
CBNK icon
5563
Capital Bancorp
CBNK
$623M
$8K ﹤0.01%
369
-159
-30% -$3.39K
CDTX
5564
DELISTED
Cidara Therapeutics
CDTX
$8K ﹤0.01%
200
-129
-39% -$5.46K
FTHM icon
5565
Fathom Holdings
FTHM
$28.9M
$8K ﹤0.01%
247
-70
-22% -$2.31K
GLV
5566
Clough Global Dividend & Income Fund
GLV
$77.7M
$8K ﹤0.01%
700
GORV
5567
DELISTED
Lazydays
GORV
$8K ﹤0.01%
+12
New +$8.18K
HBT icon
5568
HBT Financial
HBT
$1.32B
$8K ﹤0.01%
455
-193
-30% -$3.43K
IH
5569
iHuman
IH
$73.1M
$8K ﹤0.01%
760
-1,055
-58% -$11.6K
MAV
5570
DELISTED
Pioneer Municipal High Income Advantage Fund
MAV
$8K ﹤0.01%
651
-1,215
-65% -$14.7K
NODK icon
5571
NI Holdings
NODK
$320M
$8K ﹤0.01%
408
-193
-32% -$3.72K
NPCE icon
5572
Neuropace
NPCE
$523M
$8K ﹤0.01%
+331
New +$7.68K
RCON icon
5573
Recon Technology
RCON
$39.6M
$8K ﹤0.01%
+98
New +$14.3K
REPX icon
5574
Riley Exploration Permian
REPX
$716M
$8K ﹤0.01%
+278
New +$9.91K
TKC icon
5575
Turkcell
TKC
$4.79B
$8K ﹤0.01%
1,799
-440
-20% -$2.07K

Similar funds

Citigroup's Q2 2021 Portfolio in Review

As of Q2 2021, Citigroup held 6,654 positions worth $166B, up 7.5% from $155B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Citigroup's Q2 2021 filing shows 397 new, 2,681 increased, 2,205 reduced and 444 closed positions. Its largest new stake was Elliott Opportunity II Corp. Units, each consisting of one Class A ordinary share and one-fourth of one redeemable warrant: 7,128,000 shares worth $71.4M. The largest sale was Icahn Enterprises, an estimated $641M.

By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 12% a quarter earlier, followed by Financials and Healthcare.

  • Citigroup's largest Q2 2021 buy was Elliott Opportunity II Corp. Units, each consisting of one Class A ordinary share and one-fourth of one redeemable warrant: 7,128,000 shares worth $71.4M.
  • Citigroup added most to State Street SPDR S&P 500 ETF Trust in Q2 2021, an estimated $2.05B increase.
  • Citigroup's biggest Q2 2021 reduction was Icahn Enterprises, cutting an estimated $641M.
  • Citigroup fully exited RealPage, Inc. in Q2 2021, selling an estimated $226M.
  • Citigroup's ten largest holdings make up 20% of its $166B portfolio in Q2 2021.
  • Citigroup opened 397 new positions and closed 444 in Q2 2021.
  • Citigroup's portfolio value rose 7.5% quarter-over-quarter to $166B.

Based on Citigroup's 13F filing for Q2 2021, filed 10 Aug 2021.